Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07118709) titled 'A Study of KC1086 in Patients With Advanced Solid Tumors' on Aug. 1.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Beijing Konruns Pharmaceutical Co., Ltd.
Condition:
Advanced Solid Tumors Cancer
Intervention:
Drug: KC1086
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: August 2025
Target Sample Size: 66
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07118709
Published by HT Digital Content Services with permission from Health Daily D...